新华医疗
(600587)
| 流通市值：91.20亿 | | | 总市值：91.55亿 |
| 流通股本：6.04亿 | | | 总股本：6.07亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,596,425,882.17 | 2,944,731,578.33 | 2,474,624,687.68 | 2,894,880,797.16 |
| 应收票据及应收账款 | 2,088,843,282.8 | 2,017,371,235.71 | 2,223,835,058.62 | 2,123,586,427.2 |
| 其中：应收票据 | 149,112,821.79 | 137,843,290.73 | 192,117,120 | 174,444,415.24 |
| 应收账款 | 1,939,730,461.01 | 1,879,527,944.98 | 2,031,717,938.62 | 1,949,142,011.96 |
| 应收款项融资 | 100,099,725.58 | 132,770,861.89 | 72,527,581.11 | 90,303,942.62 |
| 预付款项 | 260,569,926.69 | 212,326,271.54 | 282,249,338.52 | 195,102,449.24 |
| 其他应收款合计 | 443,883,118.94 | 461,420,335.15 | 605,410,991.25 | 283,517,924.42 |
| 其中:应收利息 | 909,910.36 | 909,910.36 | 905,960.12 | 906,005.84 |
| 应收股利 | 82,341,975.92 | 82,624,827.65 | 124,110,810.13 | 124,110,810.13 |
| 存货 | 3,328,044,757.86 | 3,356,266,390.04 | 3,441,900,783.28 | 3,565,779,788.37 |
| 合同资产 | 136,934,689.45 | 136,594,510.47 | 132,809,463.69 | 130,749,367.82 |
| 一年内到期的非流动资产 | 16,602,603.99 | 19,544,666.11 | 15,557,788.76 | 23,546,101.68 |
| 其他流动资产 | 72,082,886.79 | 83,963,414.06 | 73,587,056.49 | 68,739,322.66 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 9,059,086,874.27 | 9,366,020,874.15 | 9,367,034,360.25 | 9,423,737,732.02 |
| 非流动资产: | | | | |
| 长期应收款 | 12,304,057.84 | 9,383,354.74 | 9,530,627.12 | 9,779,486.54 |
| 长期股权投资 | 1,518,261,716.52 | 1,506,671,275.58 | 1,488,841,800.85 | 1,637,293,153.9 |
| 其他权益工具投资 | 38,977,552.22 | 38,977,552.22 | 42,480,444.89 | 42,480,444.89 |
| 其他非流动金融资产 | 94,798,948.72 | 94,054,071.3 | 96,219,064.8 | 96,219,064.8 |
| 投资性房地产 | 302,234,661 | 305,327,977.88 | 306,852,470.88 | 310,114,956.27 |
| 固定资产 | 2,700,687,652.39 | 2,671,571,147.65 | 2,214,169,443.05 | 2,226,955,528.05 |
| 在建工程 | 547,228,327.49 | 466,898,330.57 | 817,141,884.45 | 757,070,380.96 |
| 使用权资产 | 36,663,594.69 | 42,114,930.41 | 44,840,255.78 | 47,866,901.02 |
| 无形资产 | 466,023,932.96 | 469,868,102.78 | 475,989,890.21 | 472,143,000.34 |
| 商誉 | 242,040,699.93 | 242,040,699.93 | 257,264,985.95 | 257,264,985.95 |
| 长期待摊费用 | 129,344,936.27 | 123,243,607.48 | 120,043,826.03 | 121,054,157.52 |
| 递延所得税资产 | 112,062,140.19 | 122,449,873.4 | 114,847,212.26 | 116,092,000.95 |
| 其他非流动资产 | 64,635,914.1 | 67,753,284.68 | 33,963,948.5 | 34,913,239.01 |
| 非流动资产平衡项目 | 0 | 0 | -0.01 | 0 |
| 非流动资产合计 | 6,265,264,134.32 | 6,160,354,208.62 | 6,022,185,854.76 | 6,129,247,300.2 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 15,324,351,008.59 | 15,526,375,082.77 | 15,389,220,215.01 | 15,552,985,032.22 |
| 流动负债: | | | | |
| 短期借款 | 909,281,427.5 | 900,609,472.27 | 871,454,954.46 | 892,623,151.26 |
| 应付票据及应付账款 | 2,647,785,828.88 | 2,754,383,905.42 | 2,523,257,134.75 | 2,589,868,252.62 |
| 其中：应付票据 | 238,105,495.59 | 313,648,341.66 | 450,252,544.59 | 577,717,094.82 |
| 应付账款 | 2,409,680,333.29 | 2,440,735,563.76 | 2,073,004,590.16 | 2,012,151,157.8 |
| 合同负债 | 1,901,370,838.77 | 2,049,292,887.66 | 2,140,506,941.31 | 2,170,238,878.25 |
| 应付职工薪酬 | 183,757,053.16 | 316,882,904.69 | 199,167,732.23 | 197,385,408.68 |
| 应交税费 | 104,357,341.53 | 79,750,169.05 | 100,233,322.89 | 105,934,297.07 |
| 其他应付款合计 | 612,304,913.54 | 675,273,606.32 | 824,708,943.93 | 867,393,525.4 |
| 应付股利 | 4,817,741.8 | 4,817,741.8 | 4,817,741.8 | 92,510,355.25 |
| 一年内到期的非流动负债 | 128,344,433.81 | 124,984,613.05 | 52,305,617.05 | 53,715,363.04 |
| 其他流动负债 | 361,182,503.94 | 335,860,516.44 | 424,125,058.62 | 405,407,788.01 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 6,848,384,341.13 | 7,237,038,074.9 | 7,135,759,705.24 | 7,282,566,664.33 |
| 非流动负债: | | | | |
| 长期借款 | 80,835,516.71 | 80,483,333.41 | 139,497,916.75 | 134,032,250.08 |
| 租赁负债 | 25,980,263.59 | 27,671,416.65 | 33,831,827.85 | 31,862,504.97 |
| 长期应付款 | 1,901,872.3 | 2,158,212.71 | 1,885,929.88 | 1,999,415.85 |
| 预计负债 | 22,355,445.55 | 22,767,402.83 | - | 19,850,000 |
| 递延收益 | 78,831,100.5 | 78,760,214.01 | 77,433,318.1 | 64,568,736.63 |
| 递延所得税负债 | 97,000,258.58 | 94,870,279.72 | 98,254,485.09 | 94,838,268.01 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 306,904,457.23 | 306,710,859.33 | 350,903,477.67 | 347,151,175.54 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 7,155,288,798.36 | 7,543,748,934.23 | 7,486,663,182.91 | 7,629,717,839.87 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 606,677,919 | 606,677,919 | 606,686,586 | 606,686,586 |
| 其他权益工具 | -73,577,993.14 | -73,577,993.14 | -73,577,993.14 | -73,577,993.14 |
| 资本公积 | 2,717,781,316.1 | 2,715,738,824.81 | 2,711,699,831.09 | 2,868,438,442.47 |
| 减:库存股 | 13,231,712.86 | 37,799,634.7 | 60,283,788 | 60,283,788 |
| 其他综合收益 | 18,618,291.37 | 18,618,291.37 | 16,457,187.18 | 16,457,187.18 |
| 专项储备 | 46,152,845.54 | 43,553,886.91 | 34,294,402.27 | 32,401,525.74 |
| 盈余公积 | 399,857,411.86 | 399,857,411.86 | 350,760,570.59 | 350,760,570.59 |
| 未分配利润 | 4,084,514,323.95 | 3,924,058,523.88 | 3,899,902,984.06 | 3,767,158,374.68 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,786,792,401.82 | 7,597,127,229.99 | 7,485,939,780.05 | 7,508,040,905.52 |
| 少数股东权益 | 382,269,808.41 | 385,498,918.55 | 416,617,252.05 | 415,226,286.83 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 8,169,062,210.23 | 7,982,626,148.54 | 7,902,557,032.1 | 7,923,267,192.35 |
| 负债和股东权益合计 | 15,324,351,008.59 | 15,526,375,082.77 | 15,389,220,215.01 | 15,552,985,032.22 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |